Total Payments
$9,539
2024 Payments
$760.04
Companies
46
Transactions
464
Medicare Patients
2,660
Medicare Billing
$277,151
Payment Breakdown by Category
Food & Beverage$9,320 (97.7%)
Education$203.08 (2.1%)
Other$15.98 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,320 | 459 | 97.7% |
| Education | $203.08 | 4 | 2.1% |
| Grant | $15.98 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,021 | 111 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,632 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,059 | 61 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $803.76 | 22 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $520.57 | 29 | $0 (2024) |
| Genentech USA, Inc. | $342.53 | 21 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $295.08 | 23 | $0 (2019) |
| GENZYME CORPORATION | $271.01 | 7 | $0 (2024) |
| Philips Electronics North America Corporation | $230.98 | 13 | $0 (2020) |
| Amgen Inc. | $203.17 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $760.04 | 21 | AstraZeneca Pharmaceuticals LP ($187.73) |
| 2023 | $949.31 | 33 | AstraZeneca Pharmaceuticals LP ($360.82) |
| 2022 | $1,388 | 59 | AstraZeneca Pharmaceuticals LP ($583.52) |
| 2021 | $1,111 | 54 | GlaxoSmithKline, LLC. ($273.27) |
| 2020 | $1,189 | 65 | GlaxoSmithKline, LLC. ($379.88) |
| 2019 | $1,962 | 109 | GlaxoSmithKline, LLC. ($447.29) |
| 2018 | $1,710 | 97 | GlaxoSmithKline, LLC. ($485.23) |
| 2017 | $470.61 | 26 | GlaxoSmithKline, LLC. ($213.20) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $120.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Respiratory | ||||||
| 08/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $148.70 | General |
| Category: Immunology | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Immunology | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Respiratory | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $38.68 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 12/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Inflammation | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Respiratory | ||||||
| 11/10/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 483 | 728 | $242,057 | $56,134 |
| 2022 | 9 | 568 | 915 | $291,971 | $69,504 |
| 2021 | 12 | 845 | 1,158 | $335,742 | $81,990 |
| 2020 | 12 | 764 | 1,042 | $279,831 | $69,523 |
Total Patients
2,660
Total Services
3,843
Medicare Billing
$277,151
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 384 | $151,557 | $35,058 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 151 | $42,351 | $9,703 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $23,865 | $5,635 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $8,933 | $1,998 | 22.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 69 | 76 | $6,295 | $1,535 | 24.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 25 | 27 | $4,872 | $1,141 | 23.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 16 | 17 | $2,862 | $733.55 | 25.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 11 | 11 | $1,323 | $330.72 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 473 | $186,968 | $45,348 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 186 | $52,196 | $11,671 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $35,806 | $8,341 | 23.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 23 | 24 | $4,336 | $1,001 | 23.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 30 | 30 | $3,739 | $922.06 | 24.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 19 | 21 | $3,532 | $844.55 | 23.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 37 | 39 | $3,246 | $806.33 | 24.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 18 | 51 | $1,817 | $460.87 | 25.4% |
| 88738 | Hemoglobin measurement | Office | 2022 | 21 | 22 | $331.32 | $109.24 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 210 | 410 | $158,662 | $39,875 | 25.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 184 | $49,980 | $12,174 | 24.4% |
| 71250 | Diagnostic ct scan of chest | Office | 2021 | 60 | 68 | $30,456 | $7,119 | 23.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $26,372 | $6,611 | 25.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 30 | $16,209 | $4,246 | 26.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 88 | 89 | $13,593 | $3,159 | 23.2% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 55 | 57 | $10,228 | $2,721 | 26.6% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 82 | 95 | $9,754 | $2,482 | 25.4% |
About Dr. Robert Lampert, MD
Dr. Robert Lampert, MD is a Pulmonary Disease healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972547206.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lampert, MD has received a total of $9,539 in payments from pharmaceutical and medical device companies, with $760.04 received in 2024. These payments were reported across 464 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,320).
As a Medicare-enrolled provider, Lampert has provided services to 2,660 Medicare beneficiaries, totaling 3,843 services with total Medicare billing of $277,151. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Las Vegas, NV
- Active Since 06/16/2006
- Last Updated 02/21/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1972547206
Products in Payments
- NUCALA (Biological) $996.29
- BREZTRI (Drug) $895.18
- DUPIXENT (Biological) $797.71
- OFEV (Drug) $628.20
- TRELEGY ELLIPTA (Drug) $523.26
- UPTRAVI (Drug) $475.79
- STIOLTO RESPIMAT (Drug) $308.55
- ANORO (Drug) $298.38
- SYMBICORT (Drug) $260.48
- Esbriet (Biological) $238.90
- Da Vinci Surgical System (Device) $187.86
- LONHALA MAGNAIR (Drug) $181.80
- BREO (Drug) $179.59
- AIRSUPRA (Drug) $152.03
- ICEfx Cryoablation System (Device) $150.19
- TUDORZA PRESSAIR (Drug) $150.00
- inCourage (Device) $149.96
- Arikayce (Drug) $138.53
- OPSUMIT MACITENTAN (Drug) $127.79
- FASENRA (Drug) $120.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Las Vegas
Naresh Singh, Md, MD
Pulmonary Disease — Payments: $194,092
Pulmonary Disease $194,092
Dr. Karan Gupta, M.d, M.D
Pulmonary Disease — Payments: $26,051
Pulmonary Disease $26,051
Vishisht Mehta, Md, MD
Pulmonary Disease — Payments: $14,634
Pulmonary Disease $14,634
Nisarg Changawala, Md, MD
Pulmonary Disease — Payments: $5,170
Pulmonary Disease $5,170
Angelica Honsberg, Md, MD
Pulmonary Disease — Payments: $3,543
Pulmonary Disease $3,543
Dr. Michael Schlachter, M.d, M.D
Pulmonary Disease — Payments: $3,172
Pulmonary Disease $3,172